BIOMAT Database Logo BIOMAT Database Logo

Suppression of B cell MIF production by T cells and soluble T cell-derived factors. 1977

S Cohen, and T Yoshida

Purified populations of guinea pig B cells from nonimmunized animals may be stimualted by PPD or LPS to produce MIF. Unfractionated lymphocyte suspensions from these animals do not produce MIF under these conditions. Reconstitution of B cells with T cells abolishes their ability to generate detectable MIF. A soluble factor obtained from stimulated T cell cultures (MIFIF) is also capable of suppressing this B cell activity. Thus suppressor T cells can interfere with lymphokine production by B cells and this effect is mediated at least in part by a soluble factor. This previously undescribed capacity of T cells may provide an explanation for the fact that B cells do not appear to play a role in reactions of cell-mediated immunity in vivo.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

S Cohen, and T Yoshida
Adenosine production by human B cells and B cell-mediated suppression of activated T cells.
July 2013, Blood,
S Cohen, and T Yoshida
Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressors (PITS)--III. Production of PITS beta factors from T-cell hybridomas.
January 1985, International journal of immunopharmacology,
S Cohen, and T Yoshida
Suppression of B cell differentiation by dialyzable humoral factors derived from pokeweed mitogen-stimulated cord T cells.
October 1980, Journal of immunology (Baltimore, Md. : 1950),
S Cohen, and T Yoshida
B cell destruction by T cell-derived factors.
October 1983, Journal of immunology (Baltimore, Md. : 1950),
S Cohen, and T Yoshida
Production of migration inhibition factor (MIF) by human established B type cell lines derived from normal and malignant tissues: studies of some factors affecting MIF release.
May 1975, Cellular immunology,
S Cohen, and T Yoshida
Suppression of polyclonal B cell activation by IgG-binding factors. Requirement for T cells.
January 1985, European journal of immunology,
S Cohen, and T Yoshida
Suppression of human IgA-B-cell maturation by IgA-binding factors requires T cells.
January 1988, International archives of allergy and applied immunology,
S Cohen, and T Yoshida
Blastogenic factors: production by T and B lymphocytes. Effect on T and B cells.
July 1977, Immunology,
S Cohen, and T Yoshida
Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressor (PITS). II. Resolution of multiple PITS beta factors.
September 1984, Cellular immunology,
S Cohen, and T Yoshida
Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions.
May 1987, Mechanisms of ageing and development,
Copied contents to your clipboard!